Johns Hopkins Medicine – Lyme Disease Research Center Receives NIH Grant Funding

Transforming Lyme Disease Research – Impact Report 2023. The Johns Hopkins Medicine – Lyme Disease Research Center has announced that they have been awarded National Institutes for Health (NIH) R01 funding to study post-treatment Lyme disease. This R01 involves five different departments at Johns Hopkins Medicine: Neurology, Psychiatry, Rheumatology, Physical Medicine and Rehabilitation, and Radiology, which highlights the value of a multidisciplinary approach to understanding the biology of Lyme disease. Members of the research team are principal investigators for two of the seven R01s awarded, and are co-investigators on a 3rd R01. 

Johns Hopkins continues to lead in research through their SLICE Studies (Studies of Lyme disease Immunology & Clinical Events). The  SLICE biorepository has supported numerous innovative research projects and collaborations from leading-edge investigators that rely on the extensive clinical and epidemiologic data and blood and tissue samples from persons with validated acute and chronic Lyme disease cases to advance the scientific understanding of Lyme disease. There are 772 participants enrolled in SLICE studies; 2,435 SLICE studies research visits, and an 82% retention rate of study participants at one year. Over 9,768 samples have been utilized by 39 different academic, scientific, and medical collaborators at 27 different institutions from this biorepository.

John Aucott, MD (The Barbara Townsend Cromwell Professor in Lyme Disease and Tick-Borne Illness Associate Professor of Medicine, Johns Hopkins University School of Medicine Director, Lyme Disease Research Center), states that “Receiving NIH R01 funding is a major milestone for our Center and validates the rigor and value of our program.” 

For More Information:

Read the Johns Hopkins Medicine-Impact Report 2023

Johns Hopkins Medicine – Lyme Disease Research Center

Read more LDA posts on Johns Hopkins Medicine